Youngok Son

Dr. Youngok Son

Department of Animal Biotechnology, Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
ABAmit Budhraja
Amit Budhraja
Youngok SonYoungok Son
Youngok Son
XWXin Wang
Xin Wang
ZZZhuo Zhang
Zhuo Zhang
XSXianglin Shi
Xianglin Shi
Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.

1 August 2012 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JLJeong-Chae Lee
Jeong-Chae Lee
Youngok SonYoungok Son
Youngok Son
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
XSXianglin Shi
Xianglin Shi

1 October 2006 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
JKJoo-Young Kim
Joo-Young Kim
Youngok SonYoungok Son
Youngok Son
SPSoon-Won Park
Soon-Won Park
JBJae-Ho Bae
Jae-Ho Bae
JCJoo Seop Chung
Joo Seop Chung
CKChi-Dug Kang
Chi-Dug Kang
In this study, we have investigated if current cancer therapeutic modalities including hyperthermia and ionizing radiation can increase the expression of NKG2D ligands in human cancer cell lines. The expressions of NKG2D ligands were induced by both heat shock and ionizing radiation in various cell lines including KM12, NCI-H23, HeLa and A375 cells with peaks at 2 h and 9 h after treatment, respectively, although inducibility of each NKG2D ligand was various depending on cell lines. During the induction of NKG2D ligands, heat shock protein 70 was induced by heat shock but not by ionizing radiation. These results were followed by increased susceptibilities to NK cell-mediated cytolysis after treatment with heat shock and ionizing radiation. These results suggest that heat shock and ionizing radiation induce NKG2D ligands and consequently might lead to increased NK cell-mediated cytotoxicity in various cancer cells.

1 October 2003 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Youngok SonYoungok Son
Youngok Son
JKJ Kim
J Kim
JLJ.-C Lim
J.-C Lim
YCY Chung
Y Chung
GCG.-H Chung
G.-H Chung
JLJ.-C Lee
J.-C Lee

1 June 2013 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YYYuanqin Yin
Yuanqin Yin
WLWenqi Li
Wenqi Li
Youngok SonYoungok Son
Youngok Son
LSLijuan Sun
Lijuan Sun
JLJian Lu
Jian Lu
ZZZhuo Zhang
Zhuo Zhang

1 November 2012 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Pratheeshkumar PoyilPratheeshkumar Poyil
Pratheeshkumar Poyil
CSChakkenchath Sreekala
Chakkenchath Sreekala
ZZZhuo Zhang
Zhuo Zhang
ABAmit Budhraja
Amit Budhraja
SDSongze Ding
Songze Ding
XSXianglin Shi
Xianglin Shi
Cancer is the second leading cause of death worldwide. There is greater need for more effective and less toxic therapeutic and preventive strategies. Natural products are becoming an important research area for novel and bioactive molecules for drug discovery. Phytochemicals and dietary compounds have been used for the treatment of cancer throughout history due to their safety, low toxicity, and general availability. Many active phytochemicals are in human clinical trials. Studies have indicated that daily consumption of dietary phytochemicals have cancer protective effects against carcinogens. They can inhibit, delay, or reverse carcinogenesis by inducing detoxifying and antioxidant enzymes systems, regulating inflammatory and proliferative signaling pathways, and inducing cell cycle arrest and apoptosis. Epidemiological studies have also revealed that high dietary intakes of fruits and vegetables reduce the risk of cancer. This review discusses potential natural cancer preventive compounds, their molecular targets, and their mechanisms of actions.